CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

Blood Establishment Registration and Product Listing

RegulatoryNeutral
AI Analysis

Summary

FDA announcement regarding mandatory registration and product listing requirements for blood product manufacturing establishments under section 510 of the Federal Food, Drug, and Cosmetic Act.

Importance:1/10
Sentiment:
0.00
blood productsFDA registrationregulatory requirementestablishment registration

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on August 17, 2026 3:59 PM

Read Original